Hydroxytyrosol and Parkinson's disease:protective actions against alpha-synuclein toxicity  

作　　者：Ruth Hornedo-Ortega Ana M.Espinosa-Oliva 

机构地区：[1]Departamento de Nutrición y Bromatología,Toxicología y Medicina Legal,Facultad de Farmacia,Universidad de Sevilla,Seville,Spain [2]Instituto de Biomedicina de Sevilla,IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla,Sevilla,Spain [3]Departamento de Bioquímica y Biología Molecular,Facultad de Farmacia,Universidad de Sevilla,Sevilla,Spain

出　　处：《Neural Regeneration Research》2024年第7期1427-1428,共2页中国神经再生研究（英文版）

基　　金：Authors are also grateful to RHO’s postdoctoral contract (Ayuda IJC2020-045695-I financed by MCIN/AEI/10.13039/501100011033,European Union NextGeneration EU/PRTR)。

摘　　要：Parkinson’s disease:Parkinson’s disease(PD) is the second most prevalent neurodegenerative disease,after Alzheimer’s disease,affecting 1%of the general population over the age of 65years.According to data from the World Health Organization(WHO),its prevalence has doubled in the past 25 years.In 2019,global estimates indicated over 8.5 million individuals with PD and it is suggested that PD caused 329000 deaths,an increase of over 100% since 2000(WHO,2022).

关 键 词：protective ALZHEIMER PREVALENCE 

分 类 号：R742.5[医药卫生—神经病学与精神病学]